Matarin Capital Management, LLC Buys Arena Pharmaceuticals Inc, Mercury General Corp, RLJ Lodging Trust, Sells Chesapeake Lodging Trust, Science Applications International Corp, Emergent BioSolutions Inc

• New Purchases: ARNA, MCY, RLJ, PRSP, ACN, CSX, PGR, SUPN, TKR, PHM, FB, ZTS, ABBV, USCR, CLX, ABC, MEET, ANIK, LPI, PRNB, COWN, JBL, VEC, TUSK, CVGI, QNST, WTBA, SYBT, TITN, SONA, VCTR, BWB, ALOT, VCEL,
• Added Positions: RGEN, ALRM, UFPI, CORT, PFBC, ARWR, MTZ, EGRX, CEIX, EVTC, CORE, TECD, PATK, WDR, HSII, CIM, MMI, BOH, EVR, SCL, CRVL, WLL, HCC, FTNT, MGRC, EME, RRC, URBN, PTEN, DDS, COKE, BID, ATKR, USNA, DKS, FOSL, PCMI, EGBN, RVI, HOMB, PRSC, LKFN, RC, BSTC, VRS, GNL, AMGN, AAPL, WIRE, ANIP, CRAI, MUSA, PUMP, EGOV, SAH, SBGI, HBM, AMPH, RDNT, OLP, GSBC, AES, INVA, SWX, INN, ARCH, LEE, DLX, HSTM, FONR, FISI, CPSI, MEDP, ONDK, MERC, MLR, WSBF,
• Reduced Positions: CHSP, EBS, AAN, CRMT, LM, PLAB, VIVO, NXGN, HT, CAR, PLUS, PNM, WNC, GBCI, AZPN, TDS, WOR, LRN, TBI, GHL, SCHN, LZB, OPB, MASI, SCVL, RDN, FFIV, DIOD, CPF, ALL, ALGT, VRSN, OFG, NGHC, KE, TNET, QUAD, FSB, NXRT, FNHC, PFE, ZEUS, BRKL, AXP, JCOM, EGP, SIGI, TPCO, CCXI, ZUMZ, ASRT, BMRC, RM, EVC, EXC, FSP, IDT, IMKTA, HRTG, VRTV, TEX, AMN, MCB, EAT, DAKT, ISBC, VLGEA, LTS, UBA, POWL, RBCAA,
• Sold Out: SAIC, WRLD, RGNX, ENDP, INTC, GHDX, REGI, NSP, BA, REX, SPGI, KSS, BRSS, URI, TREX, GATX, AGM, CARS, ENS, GCO, SAFM, NNI, HFWA, FF, NOA, UTL, SCHL, OSPN, TCF, HY, ITGR, RUBI, AMAG, DF, INT, ECHO, NTGR, CHMI, OPY, HTBI, ARLO,

For the details of Matarin Capital Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/matarin+capital+management%2C+llc/current-portfolio/portfolioportfolio

1. FTI Consulting Inc (FCN) - 232,344 shares, 1.40% of the total portfolio. Shares added by 0.89%
2. Sanmina Corp (SANM) - 602,211 shares, 1.31% of the total portfolio. Shares added by 0.90%
3. Sothebys (BID) - 311,703 shares, 1.30% of the total portfolio. Shares added by 6.15%
4. Enanta Pharmaceuticals Inc (ENTA) - 211,278 shares, 1.28% of the total portfolio. Shares added by 0.90%
5. Cogent Communications Holdings Inc (CCOI) - 296,596 shares, 1.26% of the total portfolio. Shares added by 0.87%

Matarin Capital Management, LLC initiated holding in Arena Pharmaceuticals Inc. The purchase prices were between $44.06 and $58.63, with an estimated average price of $51.59. The stock is now traded at around $57.38. The impact to a portfolio due to this purchase was 0.87%. The holding were 206,610 shares as of .

Matarin Capital Management, LLC initiated holding in Mercury General Corp. The purchase prices were between $49.5 and $62.5, with an estimated average price of $55.77. The stock is now traded at around $55.73. The impact to a portfolio due to this purchase was 0.75%. The holding were 166,639 shares as of .

Matarin Capital Management, LLC initiated holding in RLJ Lodging Trust. The purchase prices were between $17.17 and $18.91, with an estimated average price of $18.16. The stock is now traded at around $17.02. The impact to a portfolio due to this purchase was 0.64%. The holding were 503,169 shares as of .

Matarin Capital Management, LLC initiated holding in Perspecta Inc. The purchase prices were between $20.81 and $23.95, with an estimated average price of $22.46. The stock is now traded at around $22.68. The impact to a portfolio due to this purchase was 0.53%. The holding were 313,153 shares as of .

Matarin Capital Management, LLC initiated holding in Accenture PLC. The purchase prices were between $171.02 and $186.52, with an estimated average price of $179.58. The stock is now traded at around $193.57. The impact to a portfolio due to this purchase was 0.34%. The holding were 25,806 shares as of .

Matarin Capital Management, LLC initiated holding in CSX Corp. The purchase prices were between $73.95 and $80.52, with an estimated average price of $77.28. The stock is now traded at around $66.61. The impact to a portfolio due to this purchase was 0.3%. The holding were 53,272 shares as of .

Matarin Capital Management, LLC added to a holding in Repligen Corp by 437.48%. The purchase prices were between $54.2 and $85.95, with an estimated average price of $67.97. The stock is now traded at around $93.46. The impact to a portfolio due to this purchase was 0.55%. The holding were 108,280 shares as of .

Matarin Capital Management, LLC added to a holding in Alarm.com Holdings Inc by 403.00%. The purchase prices were between $52.5 and $71.14, with an estimated average price of $61.75. The stock is now traded at around $49.97. The impact to a portfolio due to this purchase was 0.48%. The holding were 155,361 shares as of .

Matarin Capital Management, LLC added to a holding in Universal Forest Products Inc by 836.61%. The purchase prices were between $29.77 and $38.06, with an estimated average price of $34.61. The stock is now traded at around $40.49. The impact to a portfolio due to this purchase was 0.46%. The holding were 189,991 shares as of .

Matarin Capital Management, LLC added to a holding in Corcept Therapeutics Inc by 177.22%. The purchase prices were between $9.78 and $12.76, with an estimated average price of $11.14. The stock is now traded at around $12.56. The impact to a portfolio due to this purchase was 0.37%. The holding were 730,188 shares as of .

Matarin Capital Management, LLC added to a holding in Preferred Bank by 601.47%. The purchase prices were between $43.77 and $50.22, with an estimated average price of $46.95. The stock is now traded at around $51.00. The impact to a portfolio due to this purchase was 0.35%. The holding were 121,129 shares as of .

Matarin Capital Management, LLC added to a holding in Arrowhead Pharmaceuticals Inc by 78.00%. The purchase prices were between $17.43 and $28.82, with an estimated average price of $21.92. The stock is now traded at around $28.85. The impact to a portfolio due to this purchase was 0.32%. The holding were 385,208 shares as of .

Matarin Capital Management, LLC sold out a holding in Science Applications International Corp. The sale prices were between $72.42 and $87.72, with an estimated average price of $78.36.

Matarin Capital Management, LLC sold out a holding in World Acceptance Corp. The sale prices were between $119.33 and $164.11, with an estimated average price of $136.44.

Matarin Capital Management, LLC sold out a holding in Regenxbio Inc. The sale prices were between $42 and $59.29, with an estimated average price of $49.93.

Matarin Capital Management, LLC sold out a holding in Endo International PLC. The sale prices were between $3.59 and $8.37, with an estimated average price of $6.32.

Matarin Capital Management, LLC sold out a holding in Genomic Health Inc. The sale prices were between $51.13 and $68.88, with an estimated average price of $59.2.

Matarin Capital Management, LLC sold out a holding in Intel Corp. The sale prices were between $43.46 and $58.82, with an estimated average price of $49.65.